Cardinal Ebitda from 2010 to 2024

CAH Stock  USD 122.63  0.19  0.16%   
Cardinal Health's EBITDA is decreasing with stable movements from year to year. EBITDA is predicted to flatten to about 1.7 B. For the period between 2010 and 2024, Cardinal Health, EBITDA quarterly trend regression had mean deviation of  747,784,246 and range of 3.1 B. View All Fundamentals
 
EBITDA  
First Reported
1985-06-30
Previous Quarter
590 M
Current Value
755 M
Quarterly Volatility
302.7 M
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cardinal Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cardinal Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 360.6 M, Interest Expense of 48.5 M or Selling General Administrative of 5.2 B, as well as many indicators such as Price To Sales Ratio of 0.21, Dividend Yield of 0.004 or PTB Ratio of 1.58. Cardinal financial statements analysis is a perfect complement when working with Cardinal Health Valuation or Volatility modules.
  
Check out the analysis of Cardinal Health Correlation against competitors.
For more detail on how to invest in Cardinal Stock please use our How to Invest in Cardinal Health guide.

Latest Cardinal Health's Ebitda Growth Pattern

Below is the plot of the Ebitda of Cardinal Health over the last few years. It is Cardinal Health's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cardinal Health's overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Pretty Stable
   Ebitda   
       Timeline  

Cardinal Ebitda Regression Statistics

Arithmetic Mean2,026,624,239
Geometric Mean1,244,644,927
Coefficient Of Variation47.41
Mean Deviation747,784,246
Median2,300,000,000
Standard Deviation960,778,993
Sample Variance923096.3T
Range3.1B
R-Value(0.13)
Mean Square Error977549.9T
R-Squared0.02
Significance0.65
Slope(27,723,053)
Total Sum of Squares12923347.8T

Cardinal Ebitda History

20241.7 B
2023B
20221.4 B
2021126 M
20201.3 B
20192.7 B
20182.7 B

About Cardinal Health Financial Statements

Investors use fundamental indicators, such as Cardinal Health's Ebitda, to determine how well the company is positioned to perform in the future. Although Cardinal Health's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
EBITDAB1.7 B

Currently Active Assets on Macroaxis

When determining whether Cardinal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cardinal Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cardinal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cardinal Health Stock:
Check out the analysis of Cardinal Health Correlation against competitors.
For more detail on how to invest in Cardinal Stock please use our How to Invest in Cardinal Health guide.
You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardinal Health. If investors know Cardinal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardinal Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
48.135
Dividend Share
2.012
Earnings Share
5.2
Revenue Per Share
921.782
Quarterly Revenue Growth
(0.04)
The market value of Cardinal Health is measured differently than its book value, which is the value of Cardinal that is recorded on the company's balance sheet. Investors also form their own opinion of Cardinal Health's value that differs from its market value or its book value, called intrinsic value, which is Cardinal Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardinal Health's market value can be influenced by many factors that don't directly affect Cardinal Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cardinal Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardinal Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardinal Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.